πŸ‡ΊπŸ‡Έ FDA
Patent

US 8927016

Producing a sustained-release preparation

granted A61KA61K9/1647A61K9/19

Quick answer

US patent 8927016 (Producing a sustained-release preparation) held by Takeda Pharmaceutical Company Limited expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K9/1647, A61K9/19, A61P, A61P15/00